👉 Trimyristate is a type of drug that belongs to the class of selective serotonin reuptake inhibitors (SSRIs). It was developed by Eli Lilly and Company in 1985. The primary mechanism of action for Trimyristate is to block the action of serotonergic neurotransmitters, specifically serotonin, on the release of dopamine from neurons. In clinical practice, trimyristate is used to treat a wide range of conditions, including anxiety disorders (such as generalized
